Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China
Objectives: Hepatitis E virus (HEV) is a single-stranded RNA virus infecting a variety of animals and humans. Little is known of HEV infection among cancer patients in China. This study provides new epidemiological data for the prevalence of HEV co-infection in cancer patients, indicating that HEV i...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971218300869 |
id |
doaj-5b93bd62925b4fe89c7bb56f63fd2a25 |
---|---|
record_format |
Article |
spelling |
doaj-5b93bd62925b4fe89c7bb56f63fd2a252020-11-24T21:56:50ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112018-06-0171C424710.1016/j.ijid.2018.04.003Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern ChinaMeng-Jie Bai0Na Zhou1Wei Dong2Guang-Xing Li3Wei Cong4Xing-Quan Zhu5State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaAffiliated Hospital of Qingdao University, Qingdao, Shandong Province, PR ChinaWeihaiwei People’s Hospital, Weihai, Shandong Province, PR ChinaState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaState Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, PR ChinaObjectives: Hepatitis E virus (HEV) is a single-stranded RNA virus infecting a variety of animals and humans. Little is known of HEV infection among cancer patients in China. This study provides new epidemiological data for the prevalence of HEV co-infection in cancer patients, indicating that HEV infection is common in this group. Methods: A total of 950 cancer patients and 950 control volunteers from Shandong Province, eastern China, were recruited to participate in this investigation. Blood samples from patients and controls were examined for anti-HEV IgG and IgM antibodies using ELISAs. Results: The overall seroprevalence of IgG and IgM antibodies to HEV was significantly higher in cancer patients (247/950, 26.0%) than in controls (123/950, 13.0%) (p < 0.001). In cancer patients, 22.7% of serum samples were anti-HEV IgG-positive, and in control subjects, 11.0% were anti-HEV IgG-positive (p < 0.001). For IgM antibodies, seroprevalence was 4.2% in cancer patients (n = 40) and 2.1% in controls (n = 20) (p = 0.009). The seroprevalence of HEV was higher in cancer patients who had dogs in their home (31.7%) when compared to other cancer patients. The highest seroprevalence of HEV infection was found in leukemia patients (32.3%), followed by liver cancer patients (31.1%); the lowest HEV seroprevalence was detected in patients with gastric cancer (18.9%). Conclusions: This investigation revealed that the seroprevalence of HEV was significantly higher in cancer patients than in controls in eastern China. Therefore, cancer patients are a high-risk population and should be kept away from sources of HEV infection.http://www.sciencedirect.com/science/article/pii/S1201971218300869Hepatitis E virusCancer patientsSeroprevalenceRisk factorsChina |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Meng-Jie Bai Na Zhou Wei Dong Guang-Xing Li Wei Cong Xing-Quan Zhu |
spellingShingle |
Meng-Jie Bai Na Zhou Wei Dong Guang-Xing Li Wei Cong Xing-Quan Zhu Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China International Journal of Infectious Diseases Hepatitis E virus Cancer patients Seroprevalence Risk factors China |
author_facet |
Meng-Jie Bai Na Zhou Wei Dong Guang-Xing Li Wei Cong Xing-Quan Zhu |
author_sort |
Meng-Jie Bai |
title |
Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China |
title_short |
Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China |
title_full |
Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China |
title_fullStr |
Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China |
title_full_unstemmed |
Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China |
title_sort |
seroprevalence and risk factors of hepatitis e virus infection in cancer patients in eastern china |
publisher |
Elsevier |
series |
International Journal of Infectious Diseases |
issn |
1201-9712 1878-3511 |
publishDate |
2018-06-01 |
description |
Objectives: Hepatitis E virus (HEV) is a single-stranded RNA virus infecting a variety of animals and humans. Little is known of HEV infection among cancer patients in China. This study provides new epidemiological data for the prevalence of HEV co-infection in cancer patients, indicating that HEV infection is common in this group.
Methods: A total of 950 cancer patients and 950 control volunteers from Shandong Province, eastern China, were recruited to participate in this investigation. Blood samples from patients and controls were examined for anti-HEV IgG and IgM antibodies using ELISAs.
Results: The overall seroprevalence of IgG and IgM antibodies to HEV was significantly higher in cancer patients (247/950, 26.0%) than in controls (123/950, 13.0%) (p < 0.001). In cancer patients, 22.7% of serum samples were anti-HEV IgG-positive, and in control subjects, 11.0% were anti-HEV IgG-positive (p < 0.001). For IgM antibodies, seroprevalence was 4.2% in cancer patients (n = 40) and 2.1% in controls (n = 20) (p = 0.009). The seroprevalence of HEV was higher in cancer patients who had dogs in their home (31.7%) when compared to other cancer patients. The highest seroprevalence of HEV infection was found in leukemia patients (32.3%), followed by liver cancer patients (31.1%); the lowest HEV seroprevalence was detected in patients with gastric cancer (18.9%).
Conclusions: This investigation revealed that the seroprevalence of HEV was significantly higher in cancer patients than in controls in eastern China. Therefore, cancer patients are a high-risk population and should be kept away from sources of HEV infection. |
topic |
Hepatitis E virus Cancer patients Seroprevalence Risk factors China |
url |
http://www.sciencedirect.com/science/article/pii/S1201971218300869 |
work_keys_str_mv |
AT mengjiebai seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina AT nazhou seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina AT weidong seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina AT guangxingli seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina AT weicong seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina AT xingquanzhu seroprevalenceandriskfactorsofhepatitisevirusinfectionincancerpatientsineasternchina |
_version_ |
1725856910202109952 |